Skip to main content
SpringerLink
Log in

The Prevalence of Avascular Necrosis in Patients Treated with Chemotherapy for Testicular Tumours

  • Conference paper
Germ Cell Tumours V

  • 110 Accesses

Abstract

Avascular necrosis (AVN) has been described as a complication of combination chemotherapy, especially where it includes intermittent high dose corticosteroids. We have recently reported five patients treated with chemotherapy for testicular tumours who developed symptomatic avascular necrosis following chemotherapy with steriods used as an antiemetic [1]. In this study we aim to assess the prevalence of avascular necrosis in patients who have received first line chemotherapy for testicular tumours.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Cook AM, Patterson H, Nicholls J, Huddart RA. Avascular necrosis in patients treated with BEP chemotherapy for testicular tumours. Clin Oncol 1999;11:126–7.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Academic Department of Radiotherapy & Oncology, The Royal Marsden NHS Trust, and Institute of Cancer Research, Downs Road, Sutton, Surrey, SM2 5PT, UK

    A. M. Cook & R. A. Huddart

  2. Department of X-Ray, The Royal Marsden NHS Trust, and Institute of Cancer Research, Downs Road, Sutton, Surrey, SM2 5PT, UK

    A. S. K. Dzik-Jurasz & A. R. Padhani

  3. Department of Computing and Information, The Royal Marsden NHS Trust, and Institute of Cancer Research, Downs Road, Sutton, Surrey, SM2 5PT, UK

    A. Norman

Authors
  1. A. M. Cook
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. S. K. Dzik-Jurasz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. R. Padhani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Norman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. A. Huddart
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. ICRF Cancer Medicine Research Unit, St James’s University Hospital, Leeds, UK

    Patricia Harnden MD, PhD, FRCPath, MBA

  2. Huddersfield Royal Infirmary, Huddersfield, UK

    Johnathan K. Joffe MB BS, MD, FRCP

  3. Yorkshire Centre for Cancer Treatments, Cookridge Hospital, Leeds, UK

    William G. Jones MB CHB, FRCR, DMRT

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag London Limited

About this paper

Cite this paper

Cook, A.M., Dzik-Jurasz, A.S.K., Padhani, A.R., Norman, A., Huddart, R.A. (2002). The Prevalence of Avascular Necrosis in Patients Treated with Chemotherapy for Testicular Tumours. In: Harnden, P., Joffe, J.K., Jones, W.G. (eds) Germ Cell Tumours V. Springer, London. https://doi.org/10.1007/978-1-4471-3281-3_47

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3281-3_47

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-3283-7

  • Online ISBN: 978-1-4471-3281-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation